BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36382346)

  • 1. Anti-cancer effect of targeting fibroblast activation protein alpha in glioblastoma through remodeling macrophage phenotype and suppressing tumor progression.
    Miao Y; Deng Y; Liu J; Wang J; Hu B; Hao S; Wang H; Zhang Z; Jin Z; Zhang Y; Li C; Zhang P; Wan H; Zhang S; Feng J; Ji N
    CNS Neurosci Ther; 2023 Mar; 29(3):878-892. PubMed ID: 36382346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast activation protein alpha is expressed by transformed and stromal cells and is associated with mesenchymal features in glioblastoma.
    Busek P; Balaziova E; Matrasova I; Hilser M; Tomas R; Syrucek M; Zemanova Z; Krepela E; Belacek J; Sedo A
    Tumour Biol; 2016 Oct; 37(10):13961-13971. PubMed ID: 27492457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenesis, Microenvironment Modulation and Clinical Potentiality of FAP in Glioblastoma: Lessons Learned from Other Solid Tumors.
    Shi Y; Kong Z; Liu P; Hou G; Wu J; Ma W; Cheng X; Wang Y
    Cells; 2021 May; 10(5):. PubMed ID: 34068501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging of Fibroblast Activation Protein Alpha Expression in a Preclinical Mouse Model of Glioma Using Positron Emission Tomography.
    Pandya DN; Sinha A; Yuan H; Mutkus L; Stumpf K; Marini FC; Wadas TJ
    Molecules; 2020 Aug; 25(16):. PubMed ID: 32806623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and role of the cell surface protease seprase/fibroblast activation protein-α (FAP-α) in astroglial tumors.
    Mentlein R; Hattermann K; Hemion C; Jungbluth AA; Held-Feindt J
    Biol Chem; 2011 Mar; 392(3):199-207. PubMed ID: 20707604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma.
    Li M; Li G; Kiyokawa J; Tirmizi Z; Richardson LG; Ning J; Das S; Martuza RL; Stemmer-Rachamimov A; Rabkin SD; Wakimoto H
    Acta Neuropathol Commun; 2020 Dec; 8(1):221. PubMed ID: 33308315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reciprocal regulation of the cholinic phenotype and epithelial-mesenchymal transition in glioblastoma cells.
    Koch K; Hartmann R; Schröter F; Suwala AK; Maciaczyk D; Krüger AC; Willbold D; Kahlert UD; Maciaczyk J
    Oncotarget; 2016 Nov; 7(45):73414-73431. PubMed ID: 27705917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual role of ARPC1B in regulating the network between tumor-associated macrophages and tumor cells in glioblastoma.
    Liu T; Zhu C; Chen X; Wu J; Guan G; Zou C; Shen S; Chen L; Cheng P; Cheng W; Wu A
    Oncoimmunology; 2022; 11(1):2031499. PubMed ID: 35111386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of Fibroblast Activation Protein by Transforming Growth Factor Beta-1 in Glioblastoma Microenvironment.
    Krepela E; Vanickova Z; Hrabal P; Zubal M; Chmielova B; Balaziova E; Vymola P; Matrasova I; Busek P; Sedo A
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33494271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular profiling of the tumor microenvironment in glioblastoma patients: correlation of microglia/macrophage polarization state with metalloprotease expression profiles and survival.
    Gjorgjevski M; Hannen R; Carl B; Li Y; Landmann E; Buchholz M; Bartsch JW; Nimsky C
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31142630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMGB1-Induced p62 Overexpression Promotes Snail-Mediated Epithelial-Mesenchymal Transition in Glioblastoma Cells via the Degradation of GSK-3β.
    Li H; Li J; Zhang G; Da Q; Chen L; Yu S; Zhou Q; Weng Z; Xin Z; Shi L; Ma L; Huang A; Qi S; Lu Y
    Theranostics; 2019; 9(7):1909-1922. PubMed ID: 31037147
    [No Abstract]   [Full Text] [Related]  

  • 12. IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein-specific PET/CT.
    Röhrich M; Loktev A; Wefers AK; Altmann A; Paech D; Adeberg S; Windisch P; Hielscher T; Flechsig P; Floca R; Leitz D; Schuster JP; Huber PE; Debus J; von Deimling A; Lindner T; Haberkorn U
    Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2569-2580. PubMed ID: 31388723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
    Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
    J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MTHFD2 suppresses glioblastoma progression via the inhibition of ERK1/2 phosphorylation.
    Huang M; Xue J; Chen Z; Zhou X; Chen M; Sun J; Xu Z; Wang S; Xu H; Du Z; Liu M
    Biochem Cell Biol; 2023 Feb; 101(1):112-124. PubMed ID: 36493392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CBF1 is clinically prognostic and serves as a target to block cellular invasion and chemoresistance of EMT-like glioblastoma cells.
    Maciaczyk D; Picard D; Zhao L; Koch K; Herrera-Rios D; Li G; Marquardt V; Pauck D; Hoerbelt T; Zhang W; Ouwens DM; Remke M; Jiang T; Steiger HJ; Maciaczyk J; Kahlert UD
    Br J Cancer; 2017 Jun; 117(1):102-112. PubMed ID: 28571041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BACH1 as a potential target for immunotherapy in glioblastomas.
    Yuan F; Cong Z; Cai X; Zhu J; Yuan L; Wang Y; Tang C; Ma C
    Int Immunopharmacol; 2022 Feb; 103():108451. PubMed ID: 34923423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TWIST1 promotes invasion through mesenchymal change in human glioblastoma.
    Mikheeva SA; Mikheev AM; Petit A; Beyer R; Oxford RG; Khorasani L; Maxwell JP; Glackin CA; Wakimoto H; González-Herrero I; Sánchez-García I; Silber JR; Horner PJ; Rostomily RC
    Mol Cancer; 2010 Jul; 9():194. PubMed ID: 20646316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stromal fibroblast activation protein alpha promotes gastric cancer progression via epithelial-mesenchymal transition through Wnt/ β-catenin pathway.
    Liu J; Huang C; Peng C; Xu F; Li Y; Yutaka Y; Xiong B; Yang X
    BMC Cancer; 2018 Nov; 18(1):1099. PubMed ID: 30419872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 20(S)-ginsenoside-Rg3 reverses temozolomide resistance and restrains epithelial-mesenchymal transition progression in glioblastoma.
    Chen Z; Wei X; Shen L; Zhu H; Zheng X
    Cancer Sci; 2019 Jan; 110(1):389-400. PubMed ID: 30431207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Epithelial-to-Mesenchymal Transition-Like Process in Glioblastoma: An Updated Systematic Review and In Silico Investigation.
    Iser IC; Pereira MB; Lenz G; Wink MR
    Med Res Rev; 2017 Mar; 37(2):271-313. PubMed ID: 27617697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.